Gaithersburg/Pune (Maryland/Maharashtra)[US/India], December 29 (ANI): Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, on Tuesday, announced that the Drugs Controller General of India (DCGI) has granted emergency use authorisatio
Home News Item Covovax authorisation is a vital step in India, where additional vaccine options are needed: Novavax CEO
Covovax authorisation is a vital step in India, where additional vaccine options are needed: Novavax CEO
december 29, 2021by Reacties uitgeschakeld voor Covovax authorisation is a vital step in India, where additional vaccine options are needed: Novavax CEO
Previous Post
Market exchange rates in China -- Dec. 29
Next Post
A look back at some of the acclaimed figures the world lost in 2021